1-9 of 9
Laurent Boissel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Providing a Homing Receptor for CAR Engineered NK Cells - Improving Cellular Immunotherapy for B-Cell Lymphoma

Nathan Thomas Schomer, BS, MS, Laurent Boissel, PhD, Karen Jiang, PhD, Hans Klingemann, MD PhD, John H. Lee, MD F.A.C.S, Patrick Soon-Shiong, MD FRCS(C), FACS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4547.
https://doi.org/10.1182/blood-2018-99-116890
Published: 2018
Journal Articles

CD19-Chimeric Antigen Receptor (CAR) Engineered Natural Killer (NK) Cell Therapy: Novel "Off the Shelf" Immunotherapy in CD20 Resistant B-Cell Non-Hodgkin Lymphoma (NHL) Cell Lines, Primary NHL Cells, and a Human Lymphoma Xenograft Model

Sneha Purvey, MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Andreas Klein, MD, Laurent Boissel, PhD, Saheli Sarkar, PhD, Tali Konry, PhD, Andrew M Evens, DO,MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 110.
https://doi.org/10.1182/blood.V130.Suppl_1.110.110
Published: 2017
Journal Articles

CD19 Target Activated Natural Killer (CD19.TaNK) Cellular Therapy: A Novel immunotherapeutic Approach to the Treatment of Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Saheli Sarkar, PhD, Pooja Sabhachandani, Frank C. Passero, Jr., MD, Sneha Purvey, MD, Laurent Boissel, PhD, Tania Konry, Andrew M Evens, DO, MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 4174.
https://doi.org/10.1182/blood.V128.22.4174.4174
Published: 2016
Journal Articles

Intra-Tumor Injection of CAR-Engineered NK Cells Induces Tumor Regression and Protection Against Tumor Re-Challenge

Laurent Boissel, PhD, Hans Klingemann, MD PhD, Junaid Khan, PhD, Patrick Soon-Shiong, MD FRCS (C), FACS
Journal: Blood
Blood (2016) 128 (22): 466.
https://doi.org/10.1182/blood.V128.22.466.466
Published: 2016
Journal Articles

Transfection of NK Cells with mRNA or Lentivirus Expressing Chimeric Antigen Receptors Results in Highly Efficient Killing of Lymphoid Malignancies and Compares Favorably with Monoclonal Antibody-Directed ADCC.

Laurent Boissel, PhD, Monica Betancur, MSc, Richard A. Van Etten, MD, PhD, Hans-Georg Klingemann, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1696.
https://doi.org/10.1182/blood.V114.22.1696.1696
Published: 2009
Journal Articles

Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies

Muthalagu Ramanathan, Su Su, Andreas Lundqvist, Maria Berg, Aleah Smith, Rebecca Lopez, Ann Williams, Erkut Bahceci, J. Philip McCoy, Laurent Boissel, Hans-Georg Klingemann, Richard Childs
Journal: Blood
Blood (2008) 112 (11): 3540.
https://doi.org/10.1182/blood.V112.11.3540.3540
Published: 2008
Journal Articles

Variable Contribution of Different Monocloncal Antibodies to NK Cell-Mediated ADCC Against Primary CLL Cells.

James Weitzman, Monica Betancur, Laurent Boissel, Arthur P. Rabinowitz, Hans Klingemann
Journal: Blood
Blood (2007) 110 (11): 4715.
https://doi.org/10.1182/blood.V110.11.4715.4715
Published: 2007
Journal Articles

Transfection with mRNA for CD19 Specific Chimeric Antigen Receptor Restores Natural Killer Cell Mediated Killing of CLL Cells.

Laurent Boissel, PhD, Monica Betancur, M.Sc., Hande Tuncer, M.D., James Weitzman, M.D., Hans Klingemann, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3110.
https://doi.org/10.1182/blood.V110.11.3110.3110
Published: 2007
Journal Articles

Co-Transplantation of Autologous Umbilical Cord Matrix Mesenchymal Stem Cells Improves Engraftment of Umbilical Cord Blood in NOD/SCID Mice.

Robb Friedman, MD, Monica Betancur, MS, Hande Tuncer, MD, Laurent Boissel, PhD, Curtis Cetrulo, MD, Hans-Georg Klingemann, MD/PhD
Journal: Blood
Blood (2006) 108 (11): 2569.
https://doi.org/10.1182/blood.V108.11.2569.2569
Published: 2006